AMD
Age-related macular degeneration
What it changes for your surgery
AMD does not rule out cataract surgery. Removing a lens that has become cloudy restores contrast and, above all, makes the retina visible again, so the macula can be monitored once more. The visual benefit, however, depends on the condition of the macula, and this is something to discuss before surgery rather than after.
It rules out the multifocal lens, and in most cases the extended depth of focus (EDOF) lens. These lenses split light between several distances, at the cost of a loss of contrast that a weakened macula cannot tolerate. A monofocal lens, toric if you have astigmatism, remains the right choice: distance vision is given priority, and reading is done with glasses and, if needed, a magnifying aid.
In refractive surgery, established AMD rules out the procedure: correcting the cornea does not restore a damaged macula.
More about this condition
What is it?
AMD is a degeneration of the macula, the central area of the retina responsible for fine vision, the vision you use to read or recognise a face. It takes two forms, which sometimes coexist: the atrophic or “dry” form, in which the cells at the centre of the retina slowly disappear; and the exudative or “wet” form, in which abnormal blood vessels from the choroid grow into the retina and destroy it, much more quickly.
The first sign is a distortion of straight lines, called metamorphopsia, followed by a permanent central blind spot. Peripheral vision stays intact: AMD does not make you blind, but it takes away your ability to read.
Risk factors and prevention
Age outweighs every other factor. Next come heredity, which multiplies the risk by four, smoking, exposure to ultraviolet light, cardiovascular disease and obesity.
Three measures have proven their worth: stopping smoking, a diet rich in green vegetables and oily fish, and wearing sunglasses. Self-monitoring with the Amsler grid, one eye at a time, helps you spot a new distortion between two consultations.
Treatment
The exudative form is treated with intravitreal anti-VEGF injections, repeated according to a personalised schedule. The earlier treatment starts, the better vision is preserved. There is not yet a curative treatment for the atrophic form; care relies on suitable nutritional supplements, low-vision rehabilitation and optical aids.
Follow-up of your AMD (injections, check-ups, adjustment of visual aids) continues at the Rueil Ma Vision practice.
SFO information leaflets (in French)
These leaflets are published by the French Society of Ophthalmology (Société Française d'Ophtalmologie, SFO) and the French national union of ophthalmologists (Syndicat National des Ophtalmologistes de France). They describe the procedure, its results, its risks and the consequences of declining treatment. They serve as the basis for informed consent, but do not replace the consultation.